112 related articles for article (PubMed ID: 1599052)
1. Plasma pharmacokinetics and therapeutic efficacy of praziquantel and 4-hydroxypraziquantel in Schistosoma japonicum-infected rabbits after oral, rectal, and intramuscular administration.
Xiao SH; You JQ; Guo HF
Am J Trop Med Hyg; 1992 May; 46(5):582-8. PubMed ID: 1599052
[TBL] [Abstract][Full Text] [Related]
2. Uptake and effect of praziquantel and the major human oxidative metabolite, 4-hydroxypraziquantel, by Schistosoma japonicum.
Xiao SH; You JQ; Guo HF; Catto BA
J Parasitol; 1991 Apr; 77(2):241-5. PubMed ID: 1901360
[TBL] [Abstract][Full Text] [Related]
3. [Studies on resistance of Schistosoma to praziquantel XIV experimental comparison of susceptibility to praziquantel between PZQ-resistant isolates and PZQ-susceptible isolates of Schistosoma japonicum in stages of adult worms, miracidia and cercariae].
Li HJ; Liang YS; Dai JR; Wang W; Qu GL; Li YZ; Xing YT; Tao YH; Qian K; Jia Y; Yang ZK; Wei JY
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Dec; 23(6):611-9. PubMed ID: 22379813
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between the effects of praziquantel on mice and rabbits with different intensities of Schistosoma japonicum infection and humoral immunity levels of the host].
Yue WJ; Xiao SH; Mei JY
Zhongguo Yao Li Xue Bao; 1989 Sep; 10(5):476-9. PubMed ID: 2515748
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of different isolates of Schistosoma japonicum from China to praziquantel.
He YX; Hu YQ; Yu QF
Southeast Asian J Trop Med Public Health; 1992 Jun; 23(2):261-3. PubMed ID: 1439978
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of single oral doses of praziquantel in treatment of schistosoma japonicum infection.
Liu YH; Wang XG; Wang QN; Qian MX; Wang RQ; Lu SZ; Liu J; Li GH; Chen YD
Chin Med J (Engl); 1986 Jun; 99(6):470-2. PubMed ID: 3100187
[No Abstract] [Full Text] [Related]
7. Comparative efficacy of levo-praziquantel and praziquantel in treatment of schistosomiasis japonica at a single dose.
Wu MH; Wei CC; Xu ZY; Yuan HC; Lian WN; Yang QJ; Chen M; Wang CZ; Zhang ZJ; Liu ZD
Chin Med J (Engl); 1991 Sep; 104(9):732-5. PubMed ID: 1935353
[TBL] [Abstract][Full Text] [Related]
8. Enantioselective analysis of praziquantel and trans-4-hydroxypraziquantel in human plasma by chiral LC-MS/MS: Application to pharmacokinetics.
Lima RM; Ferreira MA; Ponte TM; Marques MP; Takayanagui OM; Garcia HH; Coelho EB; Bonato PS; Lanchote VL
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3083-8. PubMed ID: 19665946
[TBL] [Abstract][Full Text] [Related]
9. Transdermal evaporation delivery system of praziquantel for schistosomiasis japonicum chemotherapy.
Wang L; Zheng X; Fang Y; Wang Y; Duan C; Yao B
J Pharm Sci; 2011 Jul; 100(7):2769-77. PubMed ID: 21319162
[TBL] [Abstract][Full Text] [Related]
10. [Experiment of praziquantel rectal administration in treatment of schistosomiasis in mice].
Yang Y; Wang JM; Jiang Y; Li XH; Liu Y; Zhu CG; Shi YJ
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Dec; 23(6):674-6, 686. PubMed ID: 22379825
[TBL] [Abstract][Full Text] [Related]
11. [Determination of praziquantel levels in cerebrospinal fluid and plasma in patients with cysticercosis of the central nervous system treated with praziquantel].
Jia JY
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):174-6, 189-90. PubMed ID: 1889331
[TBL] [Abstract][Full Text] [Related]
12. Praziquantel promotes protection against Schistosoma japonicum infection in mice.
Shao B; Gui X; Lu Z; Lv R; Li H; Lu K; Hong Y; Fu Z; Jin Y; Lin J; Fei C; Liu J
Acta Trop; 2023 May; 241():106874. PubMed ID: 36863502
[TBL] [Abstract][Full Text] [Related]
13. Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates.
Botros S; Mahmoud M; Hammam O; Salah F; Zidek Z; Masek K
APMIS; 2006; 114(7-8):480-91. PubMed ID: 16907853
[TBL] [Abstract][Full Text] [Related]
14. Microscopic observations on livers of rabbits and dogs infected with Schistosoma japonicum cercariae and early treatment with artemether or praziquantel.
Xiao SH; Yang YQ; Zhang CW; You JQ
Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):167-70. PubMed ID: 9772671
[TBL] [Abstract][Full Text] [Related]
15. Schistosoma japonicum: treatment of different developmental stages in mice with long-acting praziquantel implants.
Cheng L; Lei L; Guo S; Zhu C; Rong H; Guo D; Zhang L; Jiang Y; Lin J
Exp Parasitol; 2011 Nov; 129(3):254-9. PubMed ID: 21856298
[TBL] [Abstract][Full Text] [Related]
16. Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles.
Yang L; Geng Y; Li H; Zhang Y; You J; Chang Y
Pharmazie; 2009 Feb; 64(2):86-9. PubMed ID: 19320279
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of praziquantel against Schistosoma haematobium infection in children.
Tchuenté LA; Shaw DJ; Polla L; Cioli D; Vercruysse J
Am J Trop Med Hyg; 2004 Dec; 71(6):778-82. PubMed ID: 15642971
[TBL] [Abstract][Full Text] [Related]
18. Schistosoma mansoni eggs as a target for praziquantel: efficacy of oral application in mice.
Giboda M; Smith JM
J Trop Med Hyg; 1994 Apr; 97(2):98-102. PubMed ID: 8170010
[TBL] [Abstract][Full Text] [Related]
19. Immune responses in mice infected with Schistosoma japonicum and treated with praziquantel in special reference to the role of egg antigen.
Matsuda H; Nakamura S; Nogami S; Hayashi M; Tanaka H
Jpn J Exp Med; 1988 Apr; 58(2):79-86. PubMed ID: 3411793
[TBL] [Abstract][Full Text] [Related]
20. Small change, big difference: A promising praziquantel derivative designated P96 with broad-spectrum antischistosomal activity for chemotherapy of schistosomiasis japonica.
Xu J; Dong LL; Sun H; Huang P; Zhang RZ; Wang XY; Sun DQ; Xia CM
PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011215. PubMed ID: 37410790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
